If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Elequine Side Effects Reported to FDA

This is a report of a 94-year-old female patient (weight: NA) from PA, suffering from the following health symptoms/conditions: NA, who was treated with Elequine (dosage: 750 Units Nots Specified, start time: NS), combined with:

Digoxin

Antihypertensive

and developed a serious reaction and side effect(s): Dermatitis Allergic, Urinary Retention, Adverse Event after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Elequine treatment in female patients, resulting in Dermatitis Allergic side effect.

Elequine Side Effect Report#6961097-8

This report suggests a potential ElequineDeath side effect(s) that can have serious consequences. A 90-year-old female patient (weight: NA) from Costa Rica was diagnosed with the following symptoms/conditions: NA and used Elequine (dosage: NA) starting NS. After starting Elequine the patient began experiencing various side effects, including:Additional drugs used concurrently: NA. Although Elequine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.

Elequine Side Effect Report#6738092-7Ventricular Extrasystoles

This Ventricular Extrasystoles problem was reported by a physician from Guatemala. A 37-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: sinusitis. On NS this consumer started treatment with Elequine (dosage: NA). The following drugs were being taken at the same time:

Panadol

When using Elequine, the patient experienced the following unwanted symptoms/side effects: Ventricular ExtrasystolesThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Ventricular Extrasystoles, may become evident only after a product is in use by the general population.

Elequine Side Effect Report#6733291-2Ventricular Extrasystoles

This Ventricular Extrasystoles side effect was reported by a health professional from Japan. A 37-year-old male patient (weight:NA) experienced the following symptoms/conditions: sinusitis.The patient was prescribed Elequine (drug dosage: NA), which was initiated on NS. Concurrently used drugs:

Panadol

.After starting to take Elequine the consumer reported adverse symptoms, such as: Ventricular ExtrasystolesThese side effects may potentially be related to Elequine. The patient was hospitalized.

This is a report of a 36-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: urinary tract infection, who was treated with Elequine (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Hypoacusis, Nausea, Paraesthesia, Vertigo after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Elequine treatment in female patients, resulting in Hypoacusis side effect.

Elequine Side Effect Report#6674277-6Ventricular Extrasystoles

This report suggests a potential ElequineVentricular Extrasystoles side effect(s) that can have serious consequences. A 37-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: sinusitis and used Elequine (dosage: NA) starting NS. After starting Elequine the patient began experiencing various side effects, including: Ventricular ExtrasystolesAdditional drugs used concurrently:

Panadol

The patient was hospitalized. Although Elequine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Ventricular Extrasystoles, may still occur.

This Hypoacusis problem was reported by a consumer or non-health professional from Japan. A 36-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: urinary tract infection. On NS this consumer started treatment with Elequine (dosage: NA). The following drugs were being taken at the same time: NA. When using Elequine, the patient experienced the following unwanted symptoms/side effects: Hypoacusis, Nausea, Paraesthesia, VertigoAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Hypoacusis, may become evident only after a product is in use by the general population.

Elequine Side Effect Report#6360760-XVentricular Extrasystoles

This Ventricular Extrasystoles side effect was reported by a physician from Guatemala. A 37-year-old male patient (weight:NA) experienced the following symptoms/conditions: sinusitis.The patient was prescribed Elequine (drug dosage: NA), which was initiated on NS. Concurrently used drugs:

Acetaminophen

.After starting to take Elequine the consumer reported adverse symptoms, such as: Ventricular ExtrasystolesThese side effects may potentially be related to Elequine. The patient was hospitalized.

This is a report of a 57-year-old female patient (weight: NA) from United States, suffering from the following health symptoms/conditions: inflammation of wound, who was treated with Elequine 500 Mg Recon (dosage: 500 Mg 2 Day, start time:

Apr 16, 2009), combined with: NA. and developed a serious reaction and side effect(s): Arthralgia, Blood Blister, Nightmare, Tendon Disorder, Tendon Pain, Urticaria after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Elequine 500 Mg Recon treatment in female patients, resulting in Arthralgia side effect.

This report suggests a potential ElequineBradycardia side effect(s) that can have serious consequences. A 64-year-old male patient (weight: NA) from Mexico was diagnosed with the following symptoms/conditions: dental operation and used Elequine (dosage: NA) starting NS. After starting Elequine the patient began experiencing various side effects, including: Bradycardia, Hyperhidrosis, Hypotension, Ventricular ExtrasystolesAdditional drugs used concurrently:

Zaldiar

The patient was hospitalized. Although Elequine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Bradycardia, may still occur.

Elequine Side Effect Report#5829770-2Pharyngeal Oedema

This Pharyngeal Oedema problem was reported by a physician from Mexico. A 65-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: nail infection. On

Jul 18, 2008 this consumer started treatment with Elequine 750 (dosage: NA). The following drugs were being taken at the same time: NA. When using Elequine 750, the patient experienced the following unwanted symptoms/side effects: Pharyngeal OedemaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pharyngeal Oedema, may become evident only after a product is in use by the general population.

This Dyspnoea side effect was reported by a physician from Panama. A 47-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Elequine (drug dosage: NA), which was initiated on NS. Concurrently used drugs:

Fentanest

Diprivan

.After starting to take Elequine the consumer reported adverse symptoms, such as: Dyspnoea, Hypertension, Localised OedemaThese side effects may potentially be related to Elequine. The patient was hospitalized.

This is a report of a 48-year-old male patient (weight: NA) from Mexico, suffering from the following health symptoms/conditions: bronchitis,cough, who was treated with Elequine (dosage: NA, start time: NS), combined with:

Ambroxol

and developed a serious reaction and side effect(s): Confusional State, Hypotonia, Vision Blurred after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Elequine treatment in male patients, resulting in Confusional State side effect.

This report suggests a potential ElequineHypoacusis side effect(s) that can have serious consequences. A 36-year-old female patient (weight: NA) from Mexico was diagnosed with the following symptoms/conditions: NA and used Elequine (dosage: NA) starting NS. After starting Elequine the patient began experiencing various side effects, including: Hypoacusis, Nausea, Paraesthesia, VertigoAdditional drugs used concurrently: NA. Although Elequine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Hypoacusis, may still occur.

This Asthenia problem was reported by a physician from Trinidad And Tobago. A 38-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: bronchitis acute,gastritis,pain. On

Nov 09, 2006 this consumer started treatment with Elequine (dosage: NA). The following drugs were being taken at the same time:

Nexium

Acetaminophen

When using Elequine, the patient experienced the following unwanted symptoms/side effects: Asthenia, Deafness, Dysgeusia, Myalgia, Parosmia, TinnitusAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Asthenia, may become evident only after a product is in use by the general population.

This Abdominal Pain side effect was reported by a physician from Mexico. A 22-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Elequine (drug dosage: NA), which was initiated on

This is a report of a 22-year-old female patient (weight: NA) from Mexico, suffering from the following health symptoms/conditions: NA, who was treated with Elequine (dosage: NA, start time:

Sep 01, 2006), combined with: NA. and developed a serious reaction and side effect(s): Abdominal Pain, Blood Pressure Fluctuation, Dyspnoea, Skin Discolouration after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Elequine treatment in female patients, resulting in Abdominal Pain side effect.

The appearance of Elequine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Search for drug prescribing information: overdose risks, side effects, adverse reactions, and more

What are common Elequine Side Effects for Men?

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

You can use them to remind you of details that may alert your health care professional(s) to a problem

You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

Log Form

You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

Medicine Name and Dosage:

Side Effects

Scale

Date & Time

Other Medicine(s) or Treatment(s)

Scale: 1 = very mild to 10 = very bad

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Elequine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Viewing and using of this information is subject to accepting Terms Of Use. PatientsVille.com
does not provide medical advice, diagnosis or treatment. The information regarding adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be
used to estimate the incidence of side effects, adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!